DNA And Gene Chip Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

DNA And Gene Chip Market By Type (Consumables and Instruments), Product (Oligonucleotide DNA microarrays, Complementary DNA microarrays, BAC Clone chips, and Others), Application (Gene Expression, Proteomics, Genomics, Drug Discovery, Cancer Diagnosis & Treatment, Agricultural Biotechnology, and Others), End User (Academic & Government Research Institutes, Hospitals and Diagnostics Centers, Biotechnology and Pharmaceutical Companies, and Others) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

DNA And Gene Chip Market size is expected to be valued at USD 4,567.2 million in 2022 and is poised to grow at a significant CAGR of 11.8% over 2022–2028. A DNA and gene chip also commonly known as a DNA microarray is a collection of the microscopic holes where DNA resides. DNA microarrays have various applications such as measuring the expression levels of large numbers of genes simultaneously or genotyping multiple regions of a genome, proteomics, cancer detections, and drug discovery. Each DNA spot contains probes, the picomoles of a specific DNA sample. Technological advancements in computational biology, robotics, and fabrication methods for microarrays are driving the DNA and gene chip market growth across the globe. However, the popularity of Next Generation Sequencing (NGS) is hindering the global DNA and gene chip market growth in the recent past and is likely to hinder the global market in the forecasted years, although it is not yet able to completely replace microarrays due to high cost and maintenance problems. Also, stringent regulatory scenarios and entry barriers for start-up companies are key restraints of the global DNA and gene chip market. The key global companies like Thermo Fisher Scientific, Agilent Technologies, Illumina, Perkin Elmer, Arrayit Corporation, Macrogen Inc, and Asper Biotech are continuously influencing the global market through mergers, launching of new products, and massive investment in research and development sectors. On the basis of geography, North America held the major DNA and gene chip market share in the industry and is expected to dominate the market further in the forecasted years. Asia Specific region also registered the highest CAGR in 2021 and is likely to maintain the growth in the upcoming years.

Recent Market Developments:

In Sept 2020, Illumina, Inc. announced a collaboration with 54gene, a health technology company whose mission is to advance precision medicine capabilities in Africa through research, advanced molecular diagnostics, and clinical programs.

DNA And Gene Chip Market

MARKET SUMMARY
-
11.8%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 11.8%
  • Largest Market– Asia Pacific
  • Fastest Growing Market– North America

DNA And Gene Chip Market

  • The global dna and gene chip market report gives a comprehensive outlook across the globe with particular emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.
  • The report on the global dna and gene chip market gives historical, current, and future market sizes based on type, product, application, end-user, and geography.
Key Players
  • Perkin Elmer
  • Arrayit Corporation
  • Macrogen Inc
  • Asper Biotech
  • CapitalBio Corporation
DNA And Gene Chip Market Dynamics

The growing applications of DNA and gene chip such as gene expression, proteomics, genomics, drug discovery, cancer diagnosis & treatment, agricultural biotechnology, and others is driving the global market. The application, which was previously restricted to research institutions and laboratories has been extended to a wide range of activities such as Agri-genomics, which involves in the analysis of crop yield and agriculture sustainability. The availability and cost-effectiveness of reagents and consumables are boosting the market growth along with various types of applications.


North-America Got Significant Share

DNA And Gene Chip Market

On the basis of regions, the market share is divided into North America, Asia-pacific, Europe, and the Middle East, and the African region. The DNA and Gene Chip market in North America is holding the largest market revenue share in 2021, and, in the following years, it is predicted to increase rapidly. It is due to advanced healthcare infrastructure, global key players in this region, the high adoption rate of new technologies, and rapid investment in the biotech and pharmaceutical sectors. The Asia Specific region is also holding a significant market share due to increasing investment in the research and development sector.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The DNA and Gene Chip Market report provides granular level information about the market size, regional market share, historic market (2017-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and startup details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
DNA And Gene Chip Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The DNA and Gene Chip Market is projected to expand at a CAGR of 11.8% during the forecast period

Agilent Technologies, Illumina, Perkin Elmer, Arrayit Corporation, Macrogen Inc, Asper Biotech, CapitalBio Corporation

North America is the fastest-growing region for the DNA and Gene Chip Market


Report

Table Of Content

1. Executive Summary
2. Global DNA and Gene Chip Market Introduction
2.1. Global DNA and Gene Chip Market – Taxonomy
2.2. Global DNA and Gene Chip Market –Definitions
2.2.1. By Type
2.2.2. By Product
2.2.3. By Application
2.2.4. By End User
2.2.5. By Region
3. Global DNA and Gene Chip Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global DNA and Gene Chip Market Dynamic Factors – Impact Analysis
3.6. Global DNA and Gene Chip Market – Competition Landscape
3.7. Epidemiology
4. Global DNA and Gene Chip Market Analysis, 2017-2021 and Forecast, 2022-2028
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global DNA and Gene Chip Market, By Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Consumables
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Instruments
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. Global DNA and Gene Chip Market, By Product, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1. Oligonucleotide DNA microarrays
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Complementary DNA microarrays
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. BAC Clone chips
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Others
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global DNA and Gene Chip Market, By Application, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Gene Expression
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Proteomics
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Genomics
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Drug Discovery
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Cancer Diagnosis & Treatment
7.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Agricultural Biotechnology
7.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6.3. Market Opportunity Analysis
7.7. Others
7.7.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.7.3. Market Opportunity Analysis
8. Global DNA and Gene Chip Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. Academic & Government Research Institutes
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Hospitals and Diagnostics Centers
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Biotechnology and Pharmaceutical Companies
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Others
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
9. Global DNA and Gene Chip Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global DNA and Gene Chip Market – Opportunity Analysis Index, By Type, By Product, By Application, By End User, and Region, 2022-2028
10. North America DNA and Gene Chip Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Consumables
10.1.2. Instruments
10.2. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Oligonucleotide DNA microarrays
10.2.2. Complementary DNA microarrays
10.2.3. BAC Clone chips
10.2.4. Others
10.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Gene Expression
10.3.2. Proteomics
10.3.3. Genomics
10.3.4. Drug Discovery
10.3.5. Cancer Diagnosis & Treatment
10.3.6. Agricultural Biotechnology
10.3.7. Others
10.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Academic & Government Research Institutes
10.4.2. Hospitals and Diagnostics Centers
10.4.3. Biotechnology and Pharmaceutical Companies
10.4.4. Others
10.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America DNA and Gene Chip Market – Opportunity Analysis Index, By Type, By Product, By Application, By End User, and Country, 2022-2028
10.7. North America DNA and Gene Chip Market Dynamics – Trends
11. Europe DNA and Gene Chip Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Consumables
11.1.2. Instruments
11.2. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Oligonucleotide DNA microarrays
11.2.2. Complementary DNA microarrays
11.2.3. BAC Clone chips
11.2.4. Others
11.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Gene Expression
11.3.2. Proteomics
11.3.3. Genomics
11.3.4. Drug Discovery
11.3.5. Cancer Diagnosis & Treatment
11.3.6. Agricultural Biotechnology
11.3.7. Others
11.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Academic & Government Research Institutes
11.4.2. Hospitals and Diagnostics Centers
11.4.3. Biotechnology and Pharmaceutical Companies
11.4.4. Others
11.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe DNA and Gene Chip Market – Opportunity Analysis Index, By Type, By Product, By Application, By End User, and Country, 2022-2028
11.7. Europe DNA and Gene Chip Market Dynamics – Trends
12. Asia-Pacific DNA and Gene Chip Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Consumables
12.1.2. Instruments
12.2. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Oligonucleotide DNA microarrays
12.2.2. Complementary DNA microarrays
12.2.3. BAC Clone chips
12.2.4. Others
12.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gene Expression
12.3.2. Proteomics
12.3.3. Genomics
12.3.4. Drug Discovery
12.3.5. Cancer Diagnosis & Treatment
12.3.6. Agricultural Biotechnology
12.3.7. Others
12.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Academic & Government Research Institutes
12.4.2. Hospitals and Diagnostics Centers
12.4.3. Biotechnology and Pharmaceutical Companies
12.4.4. Others
12.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific DNA and Gene Chip Market – Opportunity Analysis Index, By Type, By Product, By Application, By End User, and Country, 2022-2028
12.7. Asia-Pacific DNA and Gene Chip Market Dynamics – Trends
13. Latin America DNA and Gene Chip Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Consumables
13.1.2. Instruments
13.2. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Oligonucleotide DNA microarrays
13.2.2. Complementary DNA microarrays
13.2.3. BAC Clone chips
13.2.4. Others
13.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Gene Expression
13.3.2. Proteomics
13.3.3. Genomics
13.3.4. Drug Discovery
13.3.5. Cancer Diagnosis & Treatment
13.3.6. Agricultural Biotechnology
13.3.7. Others
13.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Academic & Government Research Institutes
13.4.2. Hospitals and Diagnostics Centers
13.4.3. Biotechnology and Pharmaceutical Companies
13.4.4. Others
13.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America DNA and Gene Chip Market – Opportunity Analysis Index, By Type, By Product, By Application, By End User, and Country, 2022-2028
13.7. Latin America DNA and Gene Chip Market Dynamics – Trends
14. Middle East and Africa DNA and Gene Chip Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
14.1. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Consumables
14.1.2. Instruments
14.2. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Oligonucleotide DNA microarrays
14.2.2. Complementary DNA microarrays
14.2.3. BAC Clone chips
14.2.4. Others
14.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Gene Expression
14.3.2. Proteomics
14.3.3. Genomics
14.3.4. Drug Discovery
14.3.5. Cancer Diagnosis & Treatment
14.3.6. Agricultural Biotechnology
14.3.7. Others
14.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Academic & Government Research Institutes
14.4.2. Hospitals and Diagnostics Centers
14.4.3. Biotechnology and Pharmaceutical Companies
14.4.4. Others
14.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. MEA DNA and Gene Chip Market – Opportunity Analysis Index, By Type, By Product, By Application, By End User, and Country, 2022-2028
14.7. MEA DNA and Gene Chip Market Dynamics – Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Key Types, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Thermo Fisher Scientific
15.2.2. Agilent Technologies
15.2.3. Illumina
15.2.4. Perkin Elmer
15.2.5. Arrayit Corporation
15.2.6. Macrogen Inc
15.2.7. Asper Biotech
15.2.8. CapitalBio Corporation
15.2.9. Greiner Bio-One International GmbH
15.2.10. Microarrays Inc
15.2.11. Oxford Gene Technology
15.2.12. TOSHIBA HOKUTO ELECTRONICS CORPORATION
15.2.13. Savyon Diagnostics
15.2.14. Applied Micro Arrays
16. Research Methodology
17. Key Assumptions and Acronyms

Report

Company Profile

  • Thermo Fisher Scientific
  • Agilent Technologies
  • Illumina
  • Perkin Elmer
  • Arrayit Corporation
  • Macrogen Inc
  • Asper Biotech
  • CapitalBio Corporation
  • Greiner Bio-One International GmbH
  • Microarrays Inc
  • Oxford Gene Technology
  • TOSHIBA HOKUTO ELECTRONICS CORPORATION
  • Savyon Diagnostics
  • Applied Micro Arrays

Description

DNA And Gene Chip Market size is expected to be valued at USD 4,567.2 million in 2022 and is poised to grow at a significant CAGR of 11.8% over 2022–2028. A DNA and gene chip also commonly known as a DNA microarray is a collection of the microscopic holes where DNA resides. DNA microarrays have various applications such as measuring the expression levels of large numbers of genes simultaneously or genotyping multiple regions of a genome, proteomics, cancer detections, and drug discovery. Each DNA spot contains probes, the picomoles of a specific DNA sample. Technological advancements in computational biology, robotics, and fabrication methods for microarrays are driving the DNA and gene chip market growth across the globe. However, the popularity of Next Generation Sequencing (NGS) is hindering the global DNA and gene chip market growth in the recent past and is likely to hinder the global market in the forecasted years, although it is not yet able to completely replace microarrays due to high cost and maintenance problems. Also, stringent regulatory scenarios and entry barriers for start-up companies are key restraints of the global DNA and gene chip market. The key global companies like Thermo Fisher Scientific, Agilent Technologies, Illumina, Perkin Elmer, Arrayit Corporation, Macrogen Inc, and Asper Biotech are continuously influencing the global market through mergers, launching of new products, and massive investment in research and development sectors. On the basis of geography, North America held the major DNA and gene chip market share in the industry and is expected to dominate the market further in the forecasted years. Asia Specific region also registered the highest CAGR in 2021 and is likely to maintain the growth in the upcoming years.

Recent Market Developments:

In Sept 2020, Illumina, Inc. announced a collaboration with 54gene, a health technology company whose mission is to advance precision medicine capabilities in Africa through research, advanced molecular diagnostics, and clinical programs.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX